BIOMIN conducts first ever edition of Mycotoxin Academy in India


With over 300 customers and poultry players participating at both the editions of BIOMIN Mycotoxin Academy, the event marked a new beginning in creating awareness about the mycotoxin risk management in India and how BIOMIN continues to lead from the forefront in offering solutions to the problem.

On July 9, the first BIOMIN Mycotoxin Academy in India was held at Noormahal in Karnal, followed by another Academy at Park Plaza – Zirakpur in Chandigarh on July 11, with over 300 enthusiastic participants in both the events.

Both the events were led by Eileen Han, Regional Product Manager – Mycotoxin Risk Management, BIOMIN Asia-Pacific. Beginning with the clear introductory session on what are mycotoxins, Eileen Han in her lucid presentation proceeded to explain about the risks and impacts of mycotoxins in poultry.

“Any mycotoxins present in feed are delivered straight to the gastrointestinal tract (GIT) of the birds, the organ most affected by mycotoxins. The GIT is the most important organ for converting feed into energy, and its ability to function properly is directly linked to poultry productivity,“ she explained and added that the GIT is the biggest immune organ in the body system.

Among the major mycotoxins, DON (deoxynivalenol), ZEN (zearalenone) and FUM (fumonisins) are often overlooked when considering their impact on poultry health and productivity since their clinical symptoms are not usually obvious or visible. However, there have been a number of scientific and commercial trials that prove these Fusarium mycotoxins are closely related to some important poultry diseases.

Sharing key details from the latest BIOMIN Mycotoxin Survey Report, Eileen Han informed that BIOMIN is conducting the Mycotoxin Survey Program annually since 2004. “The accumulated number of samples is already over 75,000, which makes the program the largest worldwide data pool for mycotoxin analyses. In 2017, the analysed number of samples hit a record high,“ she pointed out.

“Taking a closer look at the results from South Asia or India, Aflatoxin (Afla) is still the biggest threat if we also consider the percentage contamination above the risk threshold. The prevalence of FUM and Ochratoxin A (OTA) in South Asia was the highest of all the Asian sub regions. However, Afla has been always the centre of attention that it is relatively well counteracted,“ she added.

According to her, the more problematic mycotoxins are rather FUM and DON. Unfortunately, in India the awareness of these Fusarium mycotoxins is low. DON is a known protein synthesis inhibitor and can interfere with the metabolism of high turn-over cells such as skin cells (epithelial cells), hepatic cells, immune cells and intestinal epithelial cells.

Some of the most frequent sub-clinical symptoms of DON contamination in feed are the reduction in feed intake, wet-droppings and a reduction in vaccine efficacy. On the other hand, FUM blocks the synthesis of complex sphingolipids that play a pivotal role in protecting nerves, muscles and membranes.

“When it comes to counteracting mycotoxins, the poultry industry tends to think of “toxin-binders” first. However, clay mineral binders are not an effective answer to all major mycotoxins. Especially not against Fusarium mycotoxins since their structures are not suitable for adsorbing by binders,“ she underlined.

She recommended that biotransformation using microbes and enzymes is the most effective strategy as it provides reliable protection for birds against Fusarium mycotoxins by biodegrading mycotoxins into non-toxic metabolites. In addition to biotransformation, a bioprotection strategy is also important. A combination of different strategies can counteract the negative effects of mycotoxins in poultry more completely, especially in cases of multi-mycotoxin contamination with the poorly absorbed Fusarium mycotoxins in poultry feed.

The Mycofix® product line from BIOMIN, which is in the forefront of mycotoxin risk management, is an unique combination of patented specific enzymes and biological components that deactivates mycotoxins in contaminated feed into non-toxic, environmentally-safe metabolites.

The key to the effectiveness of Mycofix® product line is its three-pronged strategy of mycotoxin control, namely: biotransformation, adsorption and bioprotection.

Gangga Widyanugraha, Regional Technical Sales Manager – Poultry in his presentation highlighted the prevalence of mycotoxin in poultry in India. Äccording to him, postmortem analyses of birds done by him across India corroborates the BIOMIN Mycotoxin Survey Report.

Edward Manchester, Regional Director, BIOMIN Asia Pacific in his welcome address earlier informed the participants that research and development is the cornerstone of BIOMIN. “Collaborations with global institutions and organisations strengthen the BIOMIN research core. Synergies from these research collaborations inspire us to push the boundaries of animal nutrition and continue developing customer-oriented solutions that are a step ahead of the competition,” he said.

According to him, the superior quality of the products and services of BIOMIN is evident from the number of patents and EU authorizations received by the company.

Sujit Kulkarni, Managing Director, BIOMIN India in his address said that the initiative to create awareness among the customers and poultry players on the mycotoxin risk management through such BIOMIN Mycotoxin Academies has received overwhelming response.

“We will continue to strive towards maintaining the lead in providing scientific solutions to the mycotoxin contamination and also to create awareness among the stakeholders throughout the country by conducting more editions of BIOMIN Mycotoxin Academies,“ he added.

It may be noted that the first edition of Mycotoxin Academy in India, apart from creating awareness about mycotoxin contamination and offering solutions was a cobranding event conducted by both BIOMIN and MG Marketing.